Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TP53 | P04637 | 1/20 | 0.45 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.32 |
| ▸ | ADAMTS4 | O75173 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL196164 | 1.00 | TP53 (0.45) | TP53TSHRSLC7A5ADAMTS4 | |
| SCHEMBL7424097 | 1.00 | TP53 (0.45) | TP53TSHRSLC7A5ADAMTS4 | |
| Hydrochloric Acid SCHEMBL32661867 | 0.97 | TP53 (0.43) | TP53TSHRSLC7A5ADAMTS4 | |
| SCHEMBL28001459 | 0.81 | TP53 (0.43) | TP53TSHRSLC7A5ADAMTS4 | |
| SCHEMBL18921013 | 0.80 | TP53 (0.40) | TP53SLC7A5ADAMTS4 | |
| SCHEMBL14890392 | 0.80 | TP53 (0.40) | TP53SLC7A5ADAMTS4 | |
| SCHEMBL214942 | 0.80 | TP53 (0.40) | TP53SLC7A5ADAMTS4 | |
| SCHEMBL15023 | 0.80 | TP53 (0.40) | TP53SLC7A5ADAMTS4 | |
| SCHEMBL22383998 | 0.79 | TP53 (0.41) | TP53TSHRADAMTS4 | |
| SCHEMBL26449008 | 0.79 | TP53 (0.41) | TP53TSHRSLC7A5ADAMTS4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 108 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112321490-A | Auxiliary agent and preparation method thereof | 宿迁联盛科技股份有限公司 | 2021-02-05 | — | — | CN | claimed |
| CN-112250502-A | Bio-carbon-based organic pesticide fertilizer and preparation method thereof | 贵州盈丰原生态肥业科技有限公司 | 2021-01-22 | — | — | CN | claimed |
| CN-105636975-A | Anti-inflammatory tripeptides | DR AUGUST WOLFF GMBH & CO KG ARZNEIMITTEL | 2016-06-01 | — | — | CN | claimed |
| CN-101190397-B | Absorbent for separation of carbon dioxide | KOREA ELECTRIC POWER CORP | 2011-09-14 | — | — | CN | claimed |
| CN-100532381-C | Antineoplastic compound, medicament composition and use thereof | JIANMIN WANG (CN) | 2009-08-26 | — | — | CN | claimed |
| CN-101475565-A | Anti-hypertension compound, and preparation, pharmaceutical composition and use thereof | JIANMIN WANG (CN) | 2009-07-08 | — | — | CN | claimed |
| CN-101314600-A | Antineoplastic compound, medicament composition and use thereof | JIANMIN WANG (CN) | 2008-12-03 | — | — | CN | claimed |
| US-6432896-B1 | MIXTURE; CLEANING COMPOUND; HEAT RESISTANCE | KAO CORPORATION (JP) | 2002-08-13 | — | — | US | claimed |
| EP-0979244-A1 | NOVEL CYCLOSPORIN DERIVATIVES, PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME | Aventis Pharma S.A. (FR) | 2000-02-16 | — | — | EP | claimed |
| WO-1998049193-A1 | NOVEL CYCLOSPORIN DERIVATIVES, PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME | RHONE-POULENC RORER S.A. (FR) | 1998-11-05 | — | — | WO | claimed |
| EP-3610849-B1 | METHOD FOR REMOVING KERATOTIC PLUGS | KAO CORP (JP) | 2025-09-17 | — | — | EP | disclosed |
| EP-4023304-B1 | A KERATOTIC PLUG-REMOVING COMPOSITION | KAO CORP (JP) | 2025-08-27 | — | — | EP | disclosed |
| EP-3610848-B1 | SKIN CLEANSING COMPOSITION | KAO CORP (JP) | 2025-08-27 | — | — | EP | disclosed |
| US-11975086-B2 | Method for removing keratotic plugs | KAO CORPORATION (JP) | 2024-05-07 | — | — | US | disclosed |
| CN-117580857-A | APOC-II short mimetic peptides and methods of use | 美国政府(由卫生和人类服务部的部长所代表) | 2024-02-20 | — | — | CN | disclosed |
| EP-0094412-B1 | MEDICAL PROCESS AND PREPARATION | JOHNSTON, Frederick Bertram (US) | 1987-07-22 | — | — | EP | disclosed |
| EP-0094412-A4 | MEDICAL PROCESS AND PREPARATION. | JOHNSTON FREDERICK BERTRAM | 1984-04-24 | — | — | EP | disclosed |
| EP-0094412-A1 | MEDICAL PROCESS AND PREPARATION. | JOHNSTON FREDERICK BERTRAM | 1983-11-23 | — | — | EP | disclosed |
| WO-1983001725-A1 | MEDICAL PROCESS AND PREPARATION | JOHNSTON, FREDERICK, BERTRAM | 1983-05-26 | — | — | WO | disclosed |
| US-4362745-A | Medical process and preparation | JOHNSTON FREDERICK B | 1982-12-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11975086-B2 | Method for removing keratotic plugs | PAM, MUC1, CUTA | TP53 2341/4885TSHR 4781/4885SLC7A5 4550/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.